HIV Drugs Dramatically Lower Risk of Alzheimer’s Disease, Study Finds : ScienceAlert
Breaking New Ground in Alzheimer’s Treatment: The Promise of NRTIs Recent research highlights the potential of a new class of treatments for Alzheimer’s disease. These drugs, known as nucleoside reverse transcriptase inhibitors (NRTIs), currently treat HIV and hepatitis B—showing promising results in reducing Alzheimer’s risk among those over 50. This discovery opens doors to future … Read more